Presented:

NeoGenomics Reports Revenue Growth of 20% to Record $125 Million in the Third Quarter

Read Now

Presented:

NeoGenomics Announces Plans to Expand Global Footprint in Pharma Services by Opening Clinical Research Laboratory in Suzhou, China

Read Now

Presented:

NeoGenomics Schedules Its Third Quarter Earnings Release for October 27, 2020

Read Now

Presented:

NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic

Read Now

Presented:

NeoGenomics Announces Board Appointments

Read Now

Presented:

NeoGenomics Schedules its Second Quarter Earnings Release for July 28, 2020

Read Now

Presented:

NeoGenomics To Virtually Present At The Raymond James Human Health Innovation Conference

Read Now

Presented:

NeoGenomics Launches Comprehensive Suite of Solid Tumor Liquid Biopsy Tests for Cancer Patients

Read Now

Presented:

NeoGenomics To Virtually Present At The Raymond James Human Health Innovation Conference

Read Now

Presented:

NeoGenomics To Virtually Participate In Fireside Chat At The 40th Annual William Blair Growth Stock Conference

Read Now